Loading…
Loading…
Acumen Wealth Advisors LLC cut its holdings in Thermo Fisher Scientific Inc. (NYSE: TMO) by 14.7% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 12,562 shares of the medical research company's stock after selling 2,166 shares during the period.
ImmuPharma PLC (AIM:IMM, FRA:25I), the drug discovery company, has appointed Thermo Fisher Scientific to develop and manufacture the finished form of its experimental diabetes treatment Kapiglucagon. The US group was chosen after a competitive tender, with its Patheon pharma services arm taking on the drug product workstream.
Andra AP fonden raised its holdings in shares of Thermo Fisher Scientific Inc. (NYSE: TMO) by 1,411.9% in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 57,814 shares of the medical research company's stock after acquiring an additional 53,990 shares during the
Evaluate the expected performance of Thermo Fisher (TMO) for the quarter ended June 2026, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
AIA Group Ltd lowered its position in Thermo Fisher Scientific Inc. (NYSE: TMO) by 6.2% in the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 86,693 shares of the medical research company's stock after selling 5,759 shares during
TMO readies for second-quarter 2026 earnings, with growth expected across key segments as bioproduction, clinical research and new launches support results.
On July 13, 2026, we present a detailed DCF analysis for Thermo Fisher Scientific Inc (TMO), a company currently priced at $527.05. Despite a year-to-date decli
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors authorized a quarterly cash dividend of $0.47 per common share, payable on October 15, 2026, to shareholders of record as of September 15, 2026. About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $45 billion. Our Mission is to enable our customers to make the world h.
Full call transcripts — prepared remarks + analyst Q&A — with speaker-by-speaker formatting and one-click switching across every quarter on file.
Click below to see what's inside, then upgrade to read every transcript for TMO and 80,000+ other tickers.
Transcripts source: company-published earnings calls. Speaker attribution and formatting are processed in-app.